Santhera Pharmaceuticals Holding AG (SANN) CHF0.1

Sell:14.56 CHFBuy:15.04 CHF0.34 CHF (2.33%)

Prices delayed by at least 15 minutes
Sell:14.56 CHF
Buy:15.04 CHF
Change:0.34 CHF (2.33%)
Deal now
Prices delayed by at least 15 minutes
Sell:14.56 CHF
Buy:15.04 CHF
Change:0.34 CHF (2.33%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company operates through one business segment, which is the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). The Company focuses also on development of gene therapy for the treatment of LAMA2 (Laminin Subunit Alpha 2) deficient congenital muscular dystrophy (CMD). Santhera operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

Key people

Thomas Meier
Chairman of the Board
Dario Eklund
Chief Executive Officer, Member of the Executive Management Board
Catherine Isted
Chief Financial Officer
Guenther Metz
Executive Vice President - Head Business Development, Member of the Executive Management Board
Oliver Strub
Head of Compliance
Oliver P. Kronenberg
Chief Legal Officer, Corporate Secretary, Member of the Executive Management Board
Shabir Hasham
Chief Medical Officer and Member of the Executive Management Board
Philipp Gutzwiller
Non-Executive Independent Director
Bradley C. Meyer
Non-Executive Independent Director
Otto Schwarz
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    SANN
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CH1276028821
  • Market cap
    CHF 197.58m
  • Employees
    45
  • Shares in issue
    13.51m
  • Exchange
    SIX Swiss Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.